Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
阿米万单抗联合化疗治疗EGFR 20号外显子插入突变的非小细胞肺癌:PAPILLON III期研究中治疗交叉及其他终点的影响
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01182-0
Sanborn, Rachel E; Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Cheng, Susanna; Popat, Sanjay; Ono, Akira; Lu, Shun; Majem, Margarita; Aguilar, Andres; Del Rosario Garcia Campelo, Maria; Hayashi, Hidetoshi; Lee, Kang-Yun; Lee, Se-Hoon; Delmonte, Angelo; Alatorre-Alexander, Jorge; Richardson, Gary; Santos, Victor; Dooms, Christophe; Sabari, Joshua K; Shu, Catherine A; Girard, Nicolas; Mansfield, Aaron S; Park, Keunchil; Xia, Yichuan; Bhattacharya, Archan; Buyukkaramikli, Nasuh; Perualila, Nolen; Diels, Joris; Acharya, Sandip; Chandler, Conor; Proskorovsky, Irina; Dearden, Lindsay; Wortman-Vayn, Honeylet; Mahadevia, Parthiv J; Knoblauch, Roland E; Agrawal, Trishala; Baig, Mahadi; Felip, Enriqueta